{"id":34855,"date":"2025-10-05T15:10:15","date_gmt":"2025-10-05T15:10:15","guid":{"rendered":"https:\/\/www.wallstreetzen.com\/blog\/?p=34855"},"modified":"2025-10-05T18:40:43","modified_gmt":"2025-10-05T18:40:43","slug":"5-stocks-week-of-october-6-2025","status":"publish","type":"post","link":"https:\/\/www.wallstreetzen.com\/blog\/5-stocks-week-of-october-6-2025\/","title":{"rendered":"5 Stocks to Watch: Week of 10\/6\/2025"},"content":{"rendered":"\n<p>Here\u2019s some good news: We already did your stock research for you. Here\u2019s what we\u2019ll be watching this week. (Did you miss last week\u2019s picks? <a href=\"https:\/\/www.wallstreetzen.com\/news\/5-stocks-to-watch-week-of-9-29-2025\" rel=\"noopener\" target=\"_blank\">Get them here<\/a>)<\/p>\n\n\n\n<ul>\n<li>Why <strong>Kinross Gold (<\/strong><a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nyse\/kgc\" rel=\"noopener\" target=\"_blank\"><strong>KGC<\/strong><\/a><strong>) <\/strong>is still a Buy despite 150% gains since we first alerted&nbsp;<\/li>\n\n\n\n<li>Why <strong>Charles River Laboratories (<\/strong><a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nyse\/crl\" rel=\"noopener\" target=\"_blank\"><strong>CRL<\/strong><\/a><strong>)<\/strong> could be an excellent value right now<\/li>\n\n\n\n<li><strong>Nextracker (<\/strong><a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nasdaq\/nxt\" rel=\"noopener\" target=\"_blank\"><strong>NXT<\/strong><\/a><strong>) <\/strong>dominates its industry \u2014 and something big is afoot&nbsp;<\/li>\n\n\n\n<li>Why <strong>BioMarin Pharmaceutical (<\/strong><a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nasdaq\/bmrn\" rel=\"noopener\" target=\"_blank\"><strong>BMRN<\/strong><\/a><strong>) <\/strong>is the jewel of our <a href=\"https:\/\/www.wallstreetzen.com\/stock-strategies\/buy-the-dip\" rel=\"noopener\" target=\"_blank\">Buy the Dip portfolio<\/a><\/li>\n\n\n\n<li>Could <strong>Jabil (<\/strong><a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nyse\/jbl\" rel=\"noopener\" target=\"_blank\"><strong>JBL<\/strong><\/a><strong>) <\/strong>be the comeback play of the week?<\/li>\n<\/ul>\n\n\n\n<p>_________________<\/p>\n\n\n\n<p><strong>Goldman Sachs: &#8220;More Than 1,600 New Millionaires Quietly Being Anointed Due to Breakthrough Technology&#8221;&nbsp;<\/strong>And that&#8217;s only the beginning&#8230; Jeff Bezos, Mark Zuckerberg, Bill Gates, Jensen Huang, and Elon Musk are all quietly investing millions in a secret revolutionary technology. You&#8217;ve never heard anything like this before&#8230;&nbsp;<a href=\"https:\/\/www.t2imstrk.com\/3JT986N\/CS4NH7T\/?creative_id=9867\" rel=\"noopener\" target=\"_blank\"><strong>Click here to watch this special investigative documentary.<\/strong><\/a>*<\/p>\n\n\n\n<p>*Our sponsors help keep this content free<\/p>\n\n\n\n<p>_________________<\/p>\n\n\n\n<h2>1- Jabil (<a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nyse\/jbl\" rel=\"noopener\" target=\"_blank\">NYSE: JBL<\/a>)&nbsp;<\/h2>\n\n\n\n<p><em>Jabil is a crucial behind-the-scenes player helping some of the world\u2019s biggest tech and industrial companies scale production without sacrificing speed and efficiency. It maintains a strong level of exposure to high-growth sectors such as electric vehicles and healthcare \u2014 moreover, JBL is currently showing signs of recovery after a pullback.<\/em><\/p>\n\n\n\n<p><strong>Zen Rating: <\/strong>A (Strong Buy) \u2014 <a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nyse\/jbl\" rel=\"noopener\" target=\"_blank\">see full analysis &gt;<\/a>&nbsp;&nbsp;<\/p>\n\n\n\n<p><strong>Recent Price: <\/strong>$215.69<strong> <\/strong>&nbsp;\u2014 <a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nyse\/jbl\" rel=\"noopener\" target=\"_blank\">get current quote &gt;<\/a>&nbsp;<\/p>\n\n\n\n<p><strong>Max 1-year forecast: <\/strong>$267.00&nbsp;<\/p>\n\n\n\n<p><strong>Why we\u2019re watching:<\/strong><\/p>\n\n\n\n<ul>\n<li>Jabil enjoys overwhelmingly positive coverage from Wall Street \u2014&nbsp;the stock currently has 7 Strong Buy ratings and 1 Hold rating. <a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nyse\/jbl\/stock-forecast\" rel=\"noopener\" target=\"_blank\">See the ratings<\/a>.<\/li>\n\n\n\n<li>The average 12-month price forecast for Jabil shares currently stands at $237.38, and implies a healthy 9.98% upside.<\/li>\n\n\n\n<li>Barclays researcher <a href=\"https:\/\/www.wallstreetzen.com\/analysts\/tim-long\" rel=\"noopener\" target=\"_blank\">Tim Long<\/a> (a top 4% rated analyst) maintained a Strong Buy rating on the stock following the company\u2019s Q4 and FY 2025 earnings report, and hiked his price target from $223 to a Street-high $267.&nbsp;<\/li>\n\n\n\n<li>Long said the quarter delivered a &#8220;beat&#8221; and management&#8217;s guidance, although aligning with expectations, will probably turn out to be conservative.<\/li>\n\n\n\n<li>JBL is currently the 10th highest-rated stock in the Electronic Component industry, which has an Industry Rating of A.<\/li>\n\n\n\n<li>Jabil shares rank in the 94th percentile of equities \u2014 giving them a Zen Rating of A, a recent upgrade from B (Buy).<\/li>\n\n\n\n<li>JBL <strong>ranks in the top 10% of equities in terms of two Component Grade ratings<\/strong> \u2014 Safety and <a href=\"https:\/\/www.wallstreetzen.com\/news\/how-can-ai-help-my-stock-investing?\" rel=\"noopener\" target=\"_blank\">Artificial Intelligence<\/a>.<\/li>\n\n\n\n<li>With that being said, <a href=\"https:\/\/www.wallstreetzen.com\/news\/3-fatal-flaws-of-investing-revealed?\" rel=\"noopener\" target=\"_blank\">Value<\/a> is Jabil\u2019s biggest strength \u2014 in this category, it ranks in the 96th percentile of stocks. (<a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nyse\/jbl\" rel=\"noopener\" target=\"_blank\">See all 7 Zen Component Grades here &gt;<\/a>)<\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/www.wallstreetzen.com\/rails\/active_storage\/blobs\/redirect\/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBaTBHIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--c252a4c51ae4835b5c4e6b6dd80cf8d2f9144364\/67b3679727bedffa137fa062d767265b.png\" alt=\"\"\/><\/figure>\n\n\n\n<h2>2- Kinross Gold (<a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nyse\/kgc\" rel=\"noopener\" target=\"_blank\">NYSE: KGC<\/a>)<\/h2>\n\n\n\n<p><em>Kinross Gold has gained 150% since it was added to our <\/em><a href=\"https:\/\/www.wallstreetzen.com\/stock-picks\" rel=\"noopener\" target=\"_blank\"><em>Zen Investor<\/em><\/a><em> portfolio. As gold prices hover near record highs and investors look for safe-haven assets, Kinross stands out with a solid balance sheet \u2014 making it a relatively hassle-free way to get exposure to the precious metal.<\/em><\/p>\n\n\n\n<p><strong>Zen Rating: <\/strong>B (Buy) \u2014 <a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nyse\/kgc\" rel=\"noopener\" target=\"_blank\">see full analysis &gt;<\/a>&nbsp;&nbsp;<\/p>\n\n\n\n<p><strong>Recent Price: <\/strong>$24.95 \u2014 <a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nyse\/kgc\" rel=\"noopener\" target=\"_blank\">get current quote &gt;<\/a>&nbsp;<\/p>\n\n\n\n<p><strong>Max 1-year forecast: <\/strong>$27.00<\/p>\n\n\n\n<p><strong>Why we\u2019re watching:<\/strong><\/p>\n\n\n\n<ul>\n<li>Kinross Gold shares are tracked by 5 Wall Street analysts \u2014 their coverage is split between 2 Strong Buy ratings, 2 Buy ratings, and 1 Hold rating. <a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nyse\/kgc\/stock-forecast\" rel=\"noopener\" target=\"_blank\">See the ratings<\/a>&nbsp;&nbsp;<\/li>\n\n\n\n<li>UBS equity researcher <a href=\"https:\/\/www.wallstreetzen.com\/analysts\/daniel-major\" rel=\"noopener\" target=\"_blank\">Daniel Major<\/a> (a top 18% rated analyst) recently reiterated a Strong Buy rating on the stock, and hiked his price target from $20 to a Street-high $27.<\/li>\n\n\n\n<li>In a Mining sector preview note, Major said that the &#8220;soft patch&#8221; expected in Q3 2025 has not materialized, and UBS is positive on copper, aluminum, and gold, looking ahead.<\/li>\n\n\n\n<li>At present, KGC is the 13th highest-rated stock in the Gold industry, which has an <a href=\"https:\/\/www.wallstreetzen.com\/news\/discover-the-best-stocks-in-the-best-industries\" rel=\"noopener\" target=\"_blank\">Industry Rating<\/a> of B.<\/li>\n\n\n\n<li>Kinross Gold ranks in the 89th percentile of the equities that our system tracks, giving it a Zen Rating of B.<\/li>\n\n\n\n<li>Value, in which KGC ranks in the top 13%, is one of the stock\u2019s strongest suits \u2014 as it is trading at an attractive P\/E of just 18.8x.<\/li>\n\n\n\n<li><strong>Kinross Gold shares have rallied by 137.96% since the start of the year<\/strong> \u2014 so it\u2019s no wonder that they rank in the 94th percentile in terms of Momentum.<\/li>\n\n\n\n<li>Finally, we have <a href=\"https:\/\/www.wallstreetzen.com\/news\/boring-financials-point-way-to-exciting-stock-gains?\" rel=\"noopener\" target=\"_blank\">Financials<\/a> \u2014 and due to the company\u2019s exceedingly healthy balance sheet, KGC ranks in the top 1% of stocks in this category. (<a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nyse\/kgc\" rel=\"noopener\" target=\"_blank\">See all 7 Zen Component Grades here &gt;<\/a>)&nbsp;<\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/www.wallstreetzen.com\/rails\/active_storage\/blobs\/redirect\/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBaTRHIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--3afeb9eb23f77f37f86d287e40f4d6ebce896167\/855cb27a4cdb0897eb86ac32beebbc33.png\" alt=\"\"\/><\/figure>\n\n\n\n<p>_________________<\/p>\n\n\n\n<p><strong>Goldman Sachs: &#8220;More Than 1,600 New Millionaires Quietly Being Anointed Due to Breakthrough Technology&#8221;&nbsp;<\/strong>And that&#8217;s only the beginning&#8230; Jeff Bezos, Mark Zuckerberg, Bill Gates, Jensen Huang, and Elon Musk are all quietly investing millions in a secret revolutionary technology. You&#8217;ve never heard anything like this before&#8230;&nbsp;<a href=\"https:\/\/www.t2imstrk.com\/3JT986N\/CS4NH7T\/?creative_id=9867\" rel=\"noopener\" target=\"_blank\"><strong>Click here to watch this special investigative documentary.<\/strong><\/a>*<\/p>\n\n\n\n<p>*Our sponsors help keep this content free<\/p>\n\n\n\n<p>_________________<\/p>\n\n\n\n<h2>3- Charles River Laboratories (<a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nyse\/crl\" rel=\"noopener\" target=\"_blank\">NYSE: CRL<\/a>)&nbsp;<\/h2>\n\n\n\n<p><em>Cutting-edge medicine stuff is the name of the game for CRL. It\u2019s involved in a variety of preclinical and clinical laboratory, gene therapy, and cell therapy services. The stock has seen a bevy of insider purchases and demonstrated a stable growth trajectory \u2014 to boot, growth prospects are high, and CRL is still trading at quite an attractive valuation.<\/em><\/p>\n\n\n\n<p><strong>Zen Rating: <\/strong>B (Buy) \u2014 <a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nyse\/crl\" rel=\"noopener\" target=\"_blank\">see full analysis &gt;<\/a>&nbsp;&nbsp;<\/p>\n\n\n\n<p><strong>Recent Price: <\/strong>$175.46 \u2014 <a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nyse\/crl\" rel=\"noopener\" target=\"_blank\">get current quote &gt;<\/a>&nbsp;<\/p>\n\n\n\n<p><strong>Max 1-year forecast: <\/strong>$200.00&nbsp;<\/p>\n\n\n\n<p><strong>Why we\u2019re watching:<\/strong><\/p>\n\n\n\n<ul>\n<li>Per Wall Street analysts, CRL is a consensus Buy \u2014 the stock has 3 Strong Buy ratings, 1 Buy rating, and 4 Hold ratings. <a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nyse\/crl\/stock-forecast\" rel=\"noopener\" target=\"_blank\">See the ratings<\/a>&nbsp;&nbsp;<\/li>\n\n\n\n<li>However, the average 12-month price forecast for Charles River Laboratories paints a much more bullish picture, as it sits at $173.38, a figure that implies a hefty 16.01% upside.<\/li>\n\n\n\n<li>Jefferies researcher <a href=\"https:\/\/www.wallstreetzen.com\/analysts\/david-windley\" rel=\"noopener\" target=\"_blank\">David Windley<\/a> (a top 22% rated analyst) recently upgraded the stock to a Strong Buy rating and increased his price target from $142 to $195.&nbsp;<\/li>\n\n\n\n<li>CRL stock ranks in the top 10% of the stocks that we track, giving it a <a href=\"https:\/\/www.wallstreetzen.com\/zen-ratings\" rel=\"noopener\" target=\"_blank\">Zen Rating<\/a> of B.<\/li>\n\n\n\n<li>Charles River Laboratories offers a compelling mix of <a href=\"https:\/\/www.wallstreetzen.com\/news\/3-fatal-flaws-of-investing-revealed?\" rel=\"noopener\" target=\"_blank\">Value<\/a> and Growth, as the stock ranks in the 81st and 86th percentile in these categories, respectively.<\/li>\n\n\n\n<li><a href=\"https:\/\/www.wallstreetzen.com\/news\/top-stocks-loved-by-the-smart-money-crowd?\" rel=\"noopener\" target=\"_blank\">Sentiment<\/a> is another strong suit \u2014 72.51% of the insider transactions tied to the stock in the past 12 months have been purchases, so CRL ranks in the top 11% in this category despite the aforementioned Hold ratings.<\/li>\n\n\n\n<li>However, Safety is the star of the show \u2014 in terms of this Component Grade rating, the stock <strong>ranks in the top 6% of equities<\/strong>. (<a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nyse\/crl\" rel=\"noopener\" target=\"_blank\">See all 7 Zen Component Grades here &gt;<\/a>)<\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/www.wallstreetzen.com\/rails\/active_storage\/blobs\/redirect\/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBaThHIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--0a0676ae76bde0ee1a3e0c0e29a8231ad17652ca\/5c3d10a6e44bc2738946995576426971.png\" alt=\"\"\/><\/figure>\n\n\n\n<h2>4- BioMarin Pharmaceutical (<a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nasdaq\/bmrn\" rel=\"noopener\" target=\"_blank\">NASDAQ: BMRN<\/a>)&nbsp;<\/h2>\n\n\n\n<p><em>BioMarin maintains a robust pipeline of treatments aimed at rare diseases. Despite an impressive performance in the company\u2019s last earnings report, BMRN shares are down by 8.12% on the monthly chart. However, the fundamentals are there \u2014 so now might be an opportune time to buy the dip.<\/em><\/p>\n\n\n\n<p><strong>Zen Rating: <\/strong>A (Strong Buy) \u2014 <a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nasdaq\/bmrn\" rel=\"noopener\" target=\"_blank\">see full analysis &gt;<\/a>&nbsp;&nbsp;<\/p>\n\n\n\n<p><strong>Recent Price: <\/strong>$55.57 \u2014 <a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nasdaq\/bmrn\" rel=\"noopener\" target=\"_blank\">get current quote &gt;<\/a>&nbsp;<\/p>\n\n\n\n<p><strong>Max 1-year forecast: <\/strong>$114.00&nbsp;<\/p>\n\n\n\n<p><strong>Why we\u2019re watching:<\/strong><\/p>\n\n\n\n<ul>\n<li>Analyst coverage of BMRN skews strongly to the bullish side. The stock currently has 5 Strong Buy ratings and 2 Hold ratings. <a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nasdaq\/bmrn\/stock-forecast\" rel=\"noopener\" target=\"_blank\">See the ratings<\/a>&nbsp;&nbsp;<\/li>\n\n\n\n<li>Guggenheim researcher&nbsp;<a href=\"https:\/\/www.wallstreetzen.com\/analysts\/debjit-chattopadhyay\" rel=\"noopener\" target=\"_blank\">Debjit Chattopadhyay<\/a> (a top 10% rated analyst) maintained a Strong Buy rating on the stock last month, and hiked his price target from $101 to $106.<\/li>\n\n\n\n<li>In addition, <a href=\"https:\/\/www.wallstreetzen.com\/analysts\/eliana-merle\" rel=\"noopener\" target=\"_blank\">Eliana Merle<\/a> of UBS (a top 18% rated analyst) also doubled down on a Strong Buy rating, and increased her price target from $113 to a Street-high $114.&nbsp;<\/li>\n\n\n\n<li>BioMarin Pharmaceutical shares have seen an 8.12% dip in the past month, but retain stellar fundamentals. This has <strong>secured a spot for the stock in our exclusive Zen Strategies <\/strong><a href=\"https:\/\/www.wallstreetzen.com\/stock-strategies\/buy-the-dip\" rel=\"noopener\" target=\"_blank\"><strong>Buy the Dip portfolio<\/strong><\/a>, which has an all-time annual return of 35.29%.&nbsp;<\/li>\n\n\n\n<li>BMRN has a Zen Rating of A, and currently ranks in the top 2% of the more than 4,600 stocks that we track.<\/li>\n\n\n\n<li>BioMarin enjoys the benefits of a strong balance sheet \u2014 the stock ranks in the 92nd percentile in terms of Financials.<\/li>\n\n\n\n<li>Our <a href=\"https:\/\/www.wallstreetzen.com\/news\/how-can-ai-help-my-stock-investing?\" rel=\"noopener\" target=\"_blank\">Artificial Intelligence<\/a> Component Grade rating uses a neural network trained on two decades of market data to identify likely outperformers. In this category, BMRN ranks in the top 5% of stocks.<\/li>\n\n\n\n<li>Sentiment and Value are also areas where BioMarin truly shines \u2014 in both of these areas, the stock ranks in the top 3% of equities. (<a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nasdaq\/bmrn\" rel=\"noopener\" target=\"_blank\">See all 7 Zen Component Grades here &gt;<\/a>)<\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/www.wallstreetzen.com\/rails\/active_storage\/blobs\/redirect\/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBakFHIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--866f38608c40ca21c8548a2da217bf81895b3345\/bc22ebccfe2636a8f4fa87d8562a85d3.png\" alt=\"\"\/><\/figure>\n\n\n\n<h2>5- Nextracker (<a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nasdaq\/nxt\" rel=\"noopener\" target=\"_blank\">NASDAQ: NXT<\/a>)&nbsp;<\/h2>\n\n\n\n<p><em>Nextracker has a 23% share of the global solar tracker market. The company\u2019s products are essential for keeping large-scale renewable energy projects efficient. NXT has surged by more than 80% since the start of 2025 \u2014 the company recently delivered an earnings beat (its 9th consecutive one), and we also have a hefty $4.5 billion (yes, with a b) backlog. Wanna know the best part? The stock is still trading at roughly half the wider market\u2019s average P\/E ratio.<\/em><\/p>\n\n\n\n<p><strong>Zen Rating: <\/strong>A (Strong Buy) \u2014 <a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nasdaq\/nxt\" rel=\"noopener\" target=\"_blank\">see full analysis &gt;<\/a>&nbsp;&nbsp;<\/p>\n\n\n\n<p><strong>Recent Price: <\/strong>$79.36 \u2014 <a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nasdaq\/nxt\" rel=\"noopener\" target=\"_blank\">get current quote &gt;<\/a>&nbsp;<\/p>\n\n\n\n<p><strong>Max 1-year forecast: <\/strong>$88.00&nbsp;<\/p>\n\n\n\n<p><strong>Why we\u2019re watching:<\/strong><\/p>\n\n\n\n<ul>\n<li>Nextracker shares enjoy broad support from Wall Street analysts. The stock currently has 10 Strong Buy ratings, 1 Buy rating, and 2 Hold ratings. <a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nasdaq\/nxt\/stock-forecast\" rel=\"noopener\" target=\"_blank\">See the ratings<\/a>&nbsp;<\/li>\n\n\n\n<li>JP Morgan researcher <a href=\"https:\/\/www.wallstreetzen.com\/analysts\/mark-strouse\" rel=\"noopener\" target=\"_blank\">Mark Strouse<\/a> (a top 6% rated analyst) recently maintained a Strong Buy rating on the stock and hiked his price target from $69 to $77.<\/li>\n\n\n\n<li>In a technical note, Strouse told readers they adjusted their price target after updating the target date in their Clean Energy sector model from 2025\/12 to 2026\/12.<\/li>\n\n\n\n<li>Our quant rating system, Zen Ratings, evaluates more than 4,600 stocks on the basis of 115 proprietary factors every day. Stocks that rank in the top 5% have a Zen Rating of A, which has historically corresponded to an <a href=\"https:\/\/www.wallstreetzen.com\/news\/what-is-the-key-to-success-with-zen-ratings\" rel=\"noopener\" target=\"_blank\">average annualized return of 32.52%<\/a>. At present, NXT ranks in the top 5% of equities.<\/li>\n\n\n\n<li>Each <a href=\"https:\/\/www.wallstreetzen.com\/zen-ratings\" rel=\"noopener\" target=\"_blank\">Zen Rating<\/a> is a composite score made up of 7 Component Grade ratings. For instance, Nextracker ranks in the 85th percentile in terms of <a href=\"https:\/\/www.wallstreetzen.com\/news\/3-fatal-flaws-of-investing-revealed?\" rel=\"noopener\" target=\"_blank\">Value<\/a>, on account of a very attractive 19.4x price-to-earnings (P\/E) ratio.<\/li>\n\n\n\n<li>NXT also <strong>ranks in the top 9% of stocks when it comes to Momentum<\/strong>, and the top 7% with regard to Financials. (<a href=\"https:\/\/www.wallstreetzen.com\/stocks\/us\/nasdaq\/nxt\" rel=\"noopener\" target=\"_blank\">See all 7 Zen Component Grades here &gt;<\/a>)<\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/www.wallstreetzen.com\/rails\/active_storage\/blobs\/redirect\/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBakVHIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--e816093452122166cb916be1d502c9ce760e3b1e\/adba55f59031435cb1c68f9433ef6609.png\" alt=\"\"\/><\/figure>\n\n\n\n<h2><\/h2>\n\n\n\n<p><strong>What to Do Next?<\/strong><\/p>\n\n\n\n<ul>\n<li><a href=\"https:\/\/www.wallstreetzen.com\/blog\/77-best-stocks-for-august-or-any-month\/\" rel=\"noopener\" target=\"_blank\"><strong>77 Best Stocks NOW! &gt;<\/strong><\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.wallstreetzen.com\/stock-screener\/top-best-stocks-to-buy-now-today\" rel=\"noopener\" target=\"_blank\"><strong>See All \u201cA\u201d Rated Stocks with +32.52% Average Annual Return &gt;<\/strong><\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/www.wallstreetzen.com\/stock-picks\" rel=\"noopener\" target=\"_blank\"><strong>\ufeff2 New Stocks to Buy from Steve Reitmeister<\/strong><\/a><strong> &gt;<\/strong><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Here\u2019s some good news: We already did your stock research for you. Here\u2019s what we\u2019ll be watching this week. (Did you miss last week\u2019s picks? Get them here) _________________ Goldman Sachs: &#8220;More Than 1,600 New Millionaires Quietly Being Anointed Due to Breakthrough Technology&#8221;&nbsp;And that&#8217;s only the beginning&#8230; Jeff Bezos, Mark Zuckerberg, Bill Gates, Jensen Huang, [&hellip;]<\/p>\n","protected":false},"author":22,"featured_media":34848,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false},"categories":[1],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>5 Stocks to Watch: Week of 10\/6\/2025 | WallStreetZen<\/title>\n<meta name=\"description\" content=\"5 stocks to watch for the week of 10\/6\/2025, including KGC, BMRN, and more. All vetted by our 115-factor Zen Ratings system.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.wallstreetzen.com\/blog\/5-stocks-week-of-october-6-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"5 Stocks to Watch: Week of 10\/6\/2025 | WallStreetZen\" \/>\n<meta property=\"og:description\" content=\"5 stocks to watch for the week of 10\/6\/2025, including KGC, BMRN, and more. All vetted by our 115-factor Zen Ratings system.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.wallstreetzen.com\/blog\/5-stocks-week-of-october-6-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"WallStreetZen\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-05T15:10:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-05T18:40:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.wallstreetzen.com\/blog\/wp-content\/uploads\/2025\/10\/3.-Zen-Ratings-Performance.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1236\" \/>\n\t<meta property=\"og:image:height\" content=\"692\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Jessie Moore\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@wallstreet_zen\" \/>\n<meta name=\"twitter:site\" content=\"@wallstreet_zen\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jessie Moore\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\n\t    \"@context\": \"https:\/\/schema.org\",\n\t    \"@graph\": [\n\t        {\n\t            \"@type\": \"Article\",\n\t            \"@id\": \"https:\/\/www.wallstreetzen.com\/blog\/5-stocks-week-of-october-6-2025\/#article\",\n\t            \"isPartOf\": {\n\t                \"@id\": \"https:\/\/www.wallstreetzen.com\/blog\/5-stocks-week-of-october-6-2025\/\"\n\t            },\n\t            \"author\": {\n\t                \"name\": \"Jessie Moore\",\n\t                \"@id\": \"https:\/\/www.wallstreetzen.com\/blog\/#\/schema\/person\/1ca938b8947359cfa689155a12a7e98c\"\n\t            },\n\t            \"headline\": \"5 Stocks to Watch: Week of 10\/6\/2025\",\n\t            \"datePublished\": \"2025-10-05T15:10:15+00:00\",\n\t            \"dateModified\": \"2025-10-05T18:40:43+00:00\",\n\t            \"mainEntityOfPage\": {\n\t                \"@id\": \"https:\/\/www.wallstreetzen.com\/blog\/5-stocks-week-of-october-6-2025\/\"\n\t            },\n\t            \"wordCount\": 1677,\n\t            \"publisher\": {\n\t                \"@id\": \"https:\/\/www.wallstreetzen.com\/blog\/#organization\"\n\t            },\n\t            \"inLanguage\": \"en-US\"\n\t        },\n\t        {\n\t            \"@type\": \"WebPage\",\n\t            \"@id\": \"https:\/\/www.wallstreetzen.com\/blog\/5-stocks-week-of-october-6-2025\/\",\n\t            \"url\": \"https:\/\/www.wallstreetzen.com\/blog\/5-stocks-week-of-october-6-2025\/\",\n\t            \"name\": \"5 Stocks to Watch: Week of 10\/6\/2025 | WallStreetZen\",\n\t            \"isPartOf\": {\n\t                \"@id\": \"https:\/\/www.wallstreetzen.com\/blog\/#website\"\n\t            },\n\t            \"datePublished\": \"2025-10-05T15:10:15+00:00\",\n\t            \"dateModified\": \"2025-10-05T18:40:43+00:00\",\n\t            \"description\": \"5 stocks to watch for the week of 10\/6\/2025, including KGC, BMRN, and more. All vetted by our 115-factor Zen Ratings system.\",\n\t            \"breadcrumb\": {\n\t                \"@id\": \"https:\/\/www.wallstreetzen.com\/blog\/5-stocks-week-of-october-6-2025\/#breadcrumb\"\n\t            },\n\t            \"inLanguage\": \"en-US\",\n\t            \"potentialAction\": [\n\t                {\n\t                    \"@type\": \"ReadAction\",\n\t                    \"target\": [\n\t                        \"https:\/\/www.wallstreetzen.com\/blog\/5-stocks-week-of-october-6-2025\/\"\n\t                    ]\n\t                }\n\t            ]\n\t        },\n\t        {\n\t            \"@type\": \"BreadcrumbList\",\n\t            \"@id\": \"https:\/\/www.wallstreetzen.com\/blog\/5-stocks-week-of-october-6-2025\/#breadcrumb\",\n\t            \"itemListElement\": [\n\t                {\n\t                    \"@type\": \"ListItem\",\n\t                    \"position\": 1,\n\t                    \"name\": \"Blog\",\n\t                    \"item\": \"https:\/\/www.wallstreetzen.com\/blog\/\"\n\t                },\n\t                {\n\t                    \"@type\": \"ListItem\",\n\t                    \"position\": 2,\n\t                    \"name\": \"5 Stocks to Watch: Week of 10\/6\/2025\"\n\t                }\n\t            ]\n\t        },\n\t        {\n\t            \"@type\": \"WebSite\",\n\t            \"@id\": \"https:\/\/www.wallstreetzen.com\/blog\/#website\",\n\t            \"url\": \"https:\/\/www.wallstreetzen.com\/blog\/\",\n\t            \"name\": \"WallStreetZen\",\n\t            \"description\": \"\",\n\t            \"publisher\": {\n\t                \"@id\": \"https:\/\/www.wallstreetzen.com\/blog\/#organization\"\n\t            },\n\t            \"potentialAction\": [\n\t                {\n\t                    \"@type\": \"SearchAction\",\n\t                    \"target\": {\n\t                        \"@type\": \"EntryPoint\",\n\t                        \"urlTemplate\": \"https:\/\/www.wallstreetzen.com\/blog\/?s={search_term_string}\"\n\t                    },\n\t                    \"query-input\": \"required name=search_term_string\"\n\t                }\n\t            ],\n\t            \"inLanguage\": \"en-US\"\n\t        },\n\t        {\n\t            \"@type\": \"Organization\",\n\t            \"@id\": \"https:\/\/www.wallstreetzen.com\/blog\/#organization\",\n\t            \"name\": \"WallStreetZen\",\n\t            \"url\": \"https:\/\/www.wallstreetzen.com\/blog\/\",\n\t            \"logo\": {\n\t                \"@type\": \"ImageObject\",\n\t                \"inLanguage\": \"en-US\",\n\t                \"@id\": \"https:\/\/www.wallstreetzen.com\/blog\/#\/schema\/logo\/image\/\",\n\t                \"url\": \"https:\/\/www.wallstreetzen.com\/blog\/wp-content\/uploads\/2020\/09\/main-logo.svg\",\n\t                \"contentUrl\": \"https:\/\/www.wallstreetzen.com\/blog\/wp-content\/uploads\/2020\/09\/main-logo.svg\",\n\t                \"width\": 220,\n\t                \"height\": 27,\n\t                \"caption\": \"WallStreetZen\"\n\t            },\n\t            \"image\": {\n\t                \"@id\": \"https:\/\/www.wallstreetzen.com\/blog\/#\/schema\/logo\/image\/\"\n\t            },\n\t            \"sameAs\": [\n\t                \"https:\/\/www.youtube.com\/channel\/UCMddKmLQYkPPmY5q6qckrMg\",\n\t                \"https:\/\/twitter.com\/wallstreet_zen\"\n\t            ]\n\t        },\n\t        {\n\t            \"@type\": \"Person\",\n\t            \"@id\": \"https:\/\/www.wallstreetzen.com\/blog\/#\/schema\/person\/1ca938b8947359cfa689155a12a7e98c\",\n\t            \"name\": \"Jessie Moore\",\n\t            \"image\": {\n\t                \"@type\": \"ImageObject\",\n\t                \"inLanguage\": \"en-US\",\n\t                \"@id\": \"https:\/\/www.wallstreetzen.com\/blog\/#\/schema\/person\/image\/\",\n\t                \"url\": \"https:\/\/www.wallstreetzen.com\/blog\/wp-content\/uploads\/2023\/04\/cropped-00100lPORTRAIT_00100_BURST20190601112619751_COVER-96x96.jpg\",\n\t                \"contentUrl\": \"https:\/\/www.wallstreetzen.com\/blog\/wp-content\/uploads\/2023\/04\/cropped-00100lPORTRAIT_00100_BURST20190601112619751_COVER-96x96.jpg\",\n\t                \"caption\": \"Jessie Moore\"\n\t            },\n\t            \"description\": \"Jessie Moore has been writing professionally for nearly two decades; for the past seven years, she\\\\'s focused on writing, ghostwriting, and editing in the finance space. She is a Today Show and Publisher\\\\'s Weekly-featured author who has written or ghostwritten 10+ books on a wide variety of topics, ranging from day trading to unicorns to plant care.\",\n\t            \"url\": \"https:\/\/www.wallstreetzen.com\/blog\/author\/jessiemoore\/\"\n\t        }\n\t    ]\n\t}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"5 Stocks to Watch: Week of 10\/6\/2025 | WallStreetZen","description":"5 stocks to watch for the week of 10\/6\/2025, including KGC, BMRN, and more. All vetted by our 115-factor Zen Ratings system.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.wallstreetzen.com\/blog\/5-stocks-week-of-october-6-2025\/","og_locale":"en_US","og_type":"article","og_title":"5 Stocks to Watch: Week of 10\/6\/2025 | WallStreetZen","og_description":"5 stocks to watch for the week of 10\/6\/2025, including KGC, BMRN, and more. All vetted by our 115-factor Zen Ratings system.","og_url":"https:\/\/www.wallstreetzen.com\/blog\/5-stocks-week-of-october-6-2025\/","og_site_name":"WallStreetZen","article_published_time":"2025-10-05T15:10:15+00:00","article_modified_time":"2025-10-05T18:40:43+00:00","og_image":[{"width":1236,"height":692,"url":"https:\/\/www.wallstreetzen.com\/blog\/wp-content\/uploads\/2025\/10\/3.-Zen-Ratings-Performance.png","type":"image\/png"}],"author":"Jessie Moore","twitter_card":"summary_large_image","twitter_creator":"@wallstreet_zen","twitter_site":"@wallstreet_zen","twitter_misc":{"Written by":"Jessie Moore","Est. reading time":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.wallstreetzen.com\/blog\/5-stocks-week-of-october-6-2025\/#article","isPartOf":{"@id":"https:\/\/www.wallstreetzen.com\/blog\/5-stocks-week-of-october-6-2025\/"},"author":{"name":"Jessie Moore","@id":"https:\/\/www.wallstreetzen.com\/blog\/#\/schema\/person\/1ca938b8947359cfa689155a12a7e98c"},"headline":"5 Stocks to Watch: Week of 10\/6\/2025","datePublished":"2025-10-05T15:10:15+00:00","dateModified":"2025-10-05T18:40:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.wallstreetzen.com\/blog\/5-stocks-week-of-october-6-2025\/"},"wordCount":1677,"publisher":{"@id":"https:\/\/www.wallstreetzen.com\/blog\/#organization"},"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.wallstreetzen.com\/blog\/5-stocks-week-of-october-6-2025\/","url":"https:\/\/www.wallstreetzen.com\/blog\/5-stocks-week-of-october-6-2025\/","name":"5 Stocks to Watch: Week of 10\/6\/2025 | WallStreetZen","isPartOf":{"@id":"https:\/\/www.wallstreetzen.com\/blog\/#website"},"datePublished":"2025-10-05T15:10:15+00:00","dateModified":"2025-10-05T18:40:43+00:00","description":"5 stocks to watch for the week of 10\/6\/2025, including KGC, BMRN, and more. All vetted by our 115-factor Zen Ratings system.","breadcrumb":{"@id":"https:\/\/www.wallstreetzen.com\/blog\/5-stocks-week-of-october-6-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.wallstreetzen.com\/blog\/5-stocks-week-of-october-6-2025\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.wallstreetzen.com\/blog\/5-stocks-week-of-october-6-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Blog","item":"https:\/\/www.wallstreetzen.com\/blog\/"},{"@type":"ListItem","position":2,"name":"5 Stocks to Watch: Week of 10\/6\/2025"}]},{"@type":"WebSite","@id":"https:\/\/www.wallstreetzen.com\/blog\/#website","url":"https:\/\/www.wallstreetzen.com\/blog\/","name":"WallStreetZen","description":"","publisher":{"@id":"https:\/\/www.wallstreetzen.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.wallstreetzen.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.wallstreetzen.com\/blog\/#organization","name":"WallStreetZen","url":"https:\/\/www.wallstreetzen.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.wallstreetzen.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.wallstreetzen.com\/blog\/wp-content\/uploads\/2020\/09\/main-logo.svg","contentUrl":"https:\/\/www.wallstreetzen.com\/blog\/wp-content\/uploads\/2020\/09\/main-logo.svg","width":220,"height":27,"caption":"WallStreetZen"},"image":{"@id":"https:\/\/www.wallstreetzen.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.youtube.com\/channel\/UCMddKmLQYkPPmY5q6qckrMg","https:\/\/twitter.com\/wallstreet_zen"]},{"@type":"Person","@id":"https:\/\/www.wallstreetzen.com\/blog\/#\/schema\/person\/1ca938b8947359cfa689155a12a7e98c","name":"Jessie Moore","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.wallstreetzen.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/www.wallstreetzen.com\/blog\/wp-content\/uploads\/2023\/04\/cropped-00100lPORTRAIT_00100_BURST20190601112619751_COVER-96x96.jpg","contentUrl":"https:\/\/www.wallstreetzen.com\/blog\/wp-content\/uploads\/2023\/04\/cropped-00100lPORTRAIT_00100_BURST20190601112619751_COVER-96x96.jpg","caption":"Jessie Moore"},"description":"Jessie Moore has been writing professionally for nearly two decades; for the past seven years, she\\'s focused on writing, ghostwriting, and editing in the finance space. She is a Today Show and Publisher\\'s Weekly-featured author who has written or ghostwritten 10+ books on a wide variety of topics, ranging from day trading to unicorns to plant care.","url":"https:\/\/www.wallstreetzen.com\/blog\/author\/jessiemoore\/"}]}},"_links":{"self":[{"href":"https:\/\/www.wallstreetzen.com\/blog\/wp-json\/wp\/v2\/posts\/34855"}],"collection":[{"href":"https:\/\/www.wallstreetzen.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.wallstreetzen.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.wallstreetzen.com\/blog\/wp-json\/wp\/v2\/users\/22"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wallstreetzen.com\/blog\/wp-json\/wp\/v2\/comments?post=34855"}],"version-history":[{"count":1,"href":"https:\/\/www.wallstreetzen.com\/blog\/wp-json\/wp\/v2\/posts\/34855\/revisions"}],"predecessor-version":[{"id":34856,"href":"https:\/\/www.wallstreetzen.com\/blog\/wp-json\/wp\/v2\/posts\/34855\/revisions\/34856"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.wallstreetzen.com\/blog\/wp-json\/wp\/v2\/media\/34848"}],"wp:attachment":[{"href":"https:\/\/www.wallstreetzen.com\/blog\/wp-json\/wp\/v2\/media?parent=34855"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.wallstreetzen.com\/blog\/wp-json\/wp\/v2\/categories?post=34855"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.wallstreetzen.com\/blog\/wp-json\/wp\/v2\/tags?post=34855"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}